Zentalis Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Zentalis Pharmaceuticals, Inc.‘s stocks are currently a part of 60 hedge funds’ portfolios, which represents 47.04% of the total amount of its stocks outstanding. This makes up a total of 24.86M shares of Zentalis Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -61.35% or -39.46M shares fewer. As for the holding position changes, 31.67% (19) of current hedge fund investors increased the number of shares held, 36.67% (22) of current holders sold a part of the shares held, and 11.67% (7) closed the holdings completely. 8 hedge funds are new holders of Zentalis Pharmaceuticals, Inc. stock in Q1 2023, it is 13.33% of total holders.
Hedge funds holding Zentalis Pharmaceuticals (Q2 2020 – Q1 2023)
| Q2 2020 | 61 |
|---|---|
| Q3 2020 | 66 |
| Q4 2020 | 104 |
| Q1 2021 | 92 |
| Q2 2021 | 118 |
| Q3 2021 | 114 |
| Q4 2021 | 136 |
| Q1 2022 | 124 |
| Q2 2022 | 114 |
| Q3 2022 | 116 |
| Q4 2022 | 104 |
| Q1 2023 | 60 |
Hedge funds changes in Zentalis Pharmaceuticals positions (Q2 2020 – Q1 2023)
| Q2 2020 | 61 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2020 | 8 | 36 | 9 | 3 | 10 |
| Q4 2020 | 45 | 41 | 12 | 6 | 0 |
| Q1 2021 | 12 | 38 | 26 | 24 | -8 |
| Q2 2021 | 36 | 53 | 19 | 10 | 0 |
| Q3 2021 | 15 | 60 | 28 | 18 | -7 |
| Q4 2021 | 37 | 53 | 33 | 14 | -1 |
| Q1 2022 | 16 | 46 | 46 | 28 | -12 |
| Q2 2022 | 18 | 54 | 30 | 25 | -13 |
| Q3 2022 | 22 | 47 | 33 | 19 | -5 |
| Q4 2022 | 7 | 50 | 28 | 21 | -2 |
| Q1 2023 | 8 | 19 | 22 | 7 | 4 |
Hedge funds changes in Zentalis Pharmaceuticals stock options (Q2 2020 – Q1 2023)
| Q2 2020 | 0 | 0 |
|---|---|---|
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 5,395,000 | 969,000 |
| Q3 2021 | 28,823,000 | 434,000 |
| Q4 2021 | 10,945,000 | 1,514,000 |
| Q1 2022 | 6,794,000 | 1,384,000 |
| Q2 2022 | 1,535,000 | 17,000 |
| Q3 2022 | 3,786,000 | 0 |
| Q4 2022 | 1,582,842 | 24,168 |
| Q1 2023 | 80,000 | 0 |